Total Payments
$6,634
2024 Payments
$1,675
Companies
31
Transactions
362
Medicare Patients
5,899
Medicare Billing
$322,437
Payment Breakdown by Category
Food & Beverage$6,437 (97.0%)
Education$196.72 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,437 | 357 | 97.0% |
| Education | $196.72 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,028 | 65 | $0 (2024) |
| Amgen Inc. | $867.72 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $761.09 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $463.73 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $450.53 | 27 | $0 (2024) |
| Boston Scientific Corporation | $397.47 | 24 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $396.51 | 28 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $242.49 | 19 | $0 (2024) |
| Abbott Laboratories | $224.57 | 8 | $0 (2022) |
| Daiichi Sankyo Inc. | $214.86 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,675 | 88 | E.R. Squibb & Sons, L.L.C. ($309.76) |
| 2023 | $1,319 | 67 | Janssen Pharmaceuticals, Inc ($361.98) |
| 2022 | $771.06 | 41 | Janssen Pharmaceuticals, Inc ($279.94) |
| 2021 | $762.82 | 40 | Abbott Laboratories ($201.20) |
| 2020 | $314.51 | 18 | Boston Scientific Corporation ($62.33) |
| 2019 | $308.49 | 20 | Boston Scientific Corporation ($82.48) |
| 2018 | $995.55 | 53 | Amgen Inc. ($215.50) |
| 2017 | $487.93 | 35 | Janssen Pharmaceuticals, Inc ($108.48) |
All Payment Transactions
362 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.16 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/21/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $115.43 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $12.91 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.89 | General |
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.54 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $0.24 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $0.93 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $0.27 | General |
| Category: Cardiology | ||||||
| 09/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Not Applicable | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.07 | General |
| 09/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.94 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.90 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,339 | 1,532 | $287,500 | $64,755 |
| 2022 | 20 | 1,138 | 1,334 | $201,934 | $65,671 |
| 2021 | 22 | 1,629 | 1,887 | $271,997 | $91,706 |
| 2020 | 24 | 1,793 | 1,979 | $319,405 | $100,305 |
Total Patients
5,899
Total Services
6,732
Medicare Billing
$322,437
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 169 | 275 | $80,025 | $19,267 | 24.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 340 | 346 | $68,466 | $16,890 | 24.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 72 | $20,376 | $6,229 | 30.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $13,488 | $3,164 | 23.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 49 | 49 | $13,132 | $2,722 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $11,616 | $2,322 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 36 | $7,200 | $2,104 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $6,851 | $1,679 | 24.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 27 | 27 | $9,267 | $1,496 | 16.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 198 | 232 | $8,493 | $1,378 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $4,675 | $1,195 | 25.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 64 | 65 | $8,539 | $1,172 | 13.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 15 | $7,065 | $1,133 | 16.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 13 | $6,383 | $1,059 | 16.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 52 | 52 | $5,096 | $820.59 | 16.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 52 | 52 | $3,380 | $542.13 | 16.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 43 | 43 | $3,510 | $349.60 | 10.0% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 13 | 13 | $1,313 | $301.80 | 23.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 16 | 17 | $680.00 | $224.16 | 33.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 46 | 46 | $1,376 | $222.22 | 16.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 17 | 17 | $901.00 | $215.84 | 24.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 68 | 68 | $1,648 | $145.70 | 8.8% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 18 | 18 | $4,020 | $122.91 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 175 | 314 | $42,900 | $22,276 | 51.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 300 | 304 | $59,778 | $15,975 | 26.7% |
About Dr. William Ntim, MD
Dr. William Ntim, MD is a Cardiovascular Disease healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043290794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Ntim, MD has received a total of $6,634 in payments from pharmaceutical and medical device companies, with $1,675 received in 2024. These payments were reported across 362 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,437).
As a Medicare-enrolled provider, Ntim has provided services to 5,899 Medicare beneficiaries, totaling 6,732 services with total Medicare billing of $322,437. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Charlotte, NC
- Active Since 01/19/2006
- Last Updated 07/21/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1043290794
Products in Payments
- XARELTO (Drug) $1,028
- Repatha (Biological) $549.14
- LifeVest (Device) $396.51
- ENTRESTO (Drug) $383.99
- LEQVIO (Drug) $377.10
- Corlanor (Drug) $318.58
- CAMZYOS (Drug) $272.48
- Assure WCD (Device) $242.49
- WATCHMAN (Device) $225.34
- INJECTAFER (Drug) $214.86
- ELIQUIS (Drug) $191.25
- FARXIGA (Drug) $169.63
- Kerendia (Drug) $149.92
- BRILINTA (Drug) $138.52
- Arcalyst (Drug) $133.55
- FUROSCIX (Drug) $130.84
- Impella (Device) $130.78
- PRALUENT (Drug) $108.82
- WATCHMAN Access System (Device) $99.13
- FFRct (Device) $81.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Charlotte
Frank Arko, Md, MD
Cardiovascular Disease — Payments: $3.1M
Cardiovascular Disease $3.1M
Dr. Oluseun Alli, Md, MD
Cardiovascular Disease — Payments: $454,288
Cardiovascular Disease $454,288
Jonathan Schwartz, Md, MD
Cardiovascular Disease — Payments: $160,159
Cardiovascular Disease $160,159
Stephen Rennyson, Md, MD
Cardiovascular Disease — Payments: $94,413
Cardiovascular Disease $94,413
John Pasquini, Md, MD
Cardiovascular Disease — Payments: $57,261
Cardiovascular Disease $57,261
Edward Mcmillan, Md, MD
Cardiovascular Disease — Payments: $41,685
Cardiovascular Disease $41,685